FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Glenmark Ranitidine Tablets USP 150 mg

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot number7701033A 7701826A 7702344A 7702345A 7702489A 7702706A 7702707A 7702708A 7702858A 7702859A 7702860A 7702928A 7702929A 7703196A 7703634A 7704492A 7704493A 7705159A 19190289 19190342 19190372
Where it was soldNatiowide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

CGMP Deviations: Presence of NDMA impurity detected in product.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byGlenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ foreign manufacturer
Distributed by / forGlenmark Pharmaceuticals Inc., USA Mahwah, NJ
NDC68462-248-01
Show the full FDA record
Full product labelGlenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-248-01
Recalling firmGlenmark Pharmaceuticals Inc., USA
DistributionNatiowide
Quantity217,956 bottles
Recall initiated2019-12-17
Report date2020-01-15
Recall completed
Recall numberD-0640-2020
ClassificationClass II
FDA statusOngoing
Origin on fileMahwah NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.